TTrialPathMatch Me to Trials
← Back to trials
RecruitingHearing Loss, SensorineuralHearing LossHearing Loss, Bilateral

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Eligible age

18–79 yrs

Accepts

All genders

Locations

5 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).

Sponsor: Ohio State University

You may qualify if…

  • ✓ 1. Provision of signed and dated informed consent form.
  • ✓ 2. Adults, males and females, ages 18 -79 who have a bilateral sensorineural hearing loss with postlingual onset.
  • ✓ 3. Minimum of 30 days experience with appropriately fit binaural amplification (standardized National Acoustic Laboratories (NAL) fitting method) verified with real ear measurements within 5 dB SPL of targets.
  • ✓ 4. Limited benefit from conventional amplification in the best aided condition as defined by test scores of:
  • ✓ 1. The ear to implanted: Consonant-nucleus-consonant (CNC) words ≤ 60% or AzBio sentences (+10, +5 dB SNR ≤ 60% correct)
  • ✓ 2. Contralateral ear: ≤ 80% on CNC words or AzBio sentences (+10, +5 dB SNR ≤ 80% correct)
  • ✓ 5. Low frequency Pure Tone Average (PTA- 125, 250, 500 Hz) ≤ 55 dB HL in the ear to be implanted.
  • ✓ 6. Severe to profound mid to high-frequency sensorineural hearing loss (threshold average of 1000, 2000, 3000, and 4000 Hz ≥75 dB HL) in the ear to be implanted.

You may not qualify if…

  • ✕ 1. Previous cochlear implantation.
  • ✕ 2. Prelingual onset of hearing loss.
  • ✕ 3. Abnormal inner ear anatomy on CT imaging.
  • ✕ 4. Auditory neuropathy spectrum disorder.
  • ✕ 5. Retrocochlear pathology such as a vestibular schwannoma or stroke.
  • ✕ 6. Unwillingness or inability to comply with all investigational requirements including the randomization process.
  • ✕ 7. Additional medical, or social barriers that would prevent completion of all study requirements.
  • ✕ 8. Medical condition contraindicated for surgery.

Where it's recruiting

Minnesota

Rochester

Missouri

St Louis

North Carolina

Chapel Hill

Ohio

Columbus

Wisconsin

Milwaukee

Source: ClinicalTrials.gov · NCT04707885 · last updated 2025-09-12

Clinical Utility of Residual Hearing in the Cochlear Implant Ear · TrialPath